Skip to main content

Table 2 Demographic data and participants’ results for clinical outcomes

From: Comparison of walking variations during treadmill walking test between neurogenic and vascular claudication: a crossover study

  LSS group
(n = 23)
PAD group
(n = 14)
nLBP group
(n = 18)
p-value
F:M 9:14 5:9 10:8 N/A
Age (years) 70.00 ± 7.66 72.43 ± 9.41 52.00 ± 9.29 < 0.001*†
Weight (kg) 82.02 ± 14.76 83.20 ± 22.15 82.26 ± 9.95 0.975
Height (m) 1.68 ± 0.09 1.89 ± 0.80 1.69 ± 0.07 0.265
BMI (kg/m2) 29.02 ± 4.05 27.65 ± 9.02 28.85 ± 3.51 0.756
Leg pain intensity in the past week (/10) 5.63 ± 2.19 6.04 ± 2.06 3.74 ± 2.33 0.008*†
WIQdistance (%) 34.91 ± 30.30 24.34 ± 31.62 89.54 ± 17.97 0.001*†
WIQspeed (%) 31.00 ± 20.49 23.99 ± 24.33 75.24 ± 20.67 < 0.001* †
WIQstairs (%) 20.92 ± 14.51 15.19 ± 15.82 41.88 ± 10.66 < 0.001* †
WIQmean (%) 28.94 ± 20.52 21.17 ± 22.87 68.89 ± 14.20 < 0.001* †
FC-SSSQpain (/35) 20.87 ± 4.25 21.86 ± 3.46 14.17 ± 4.00 < 0.001* †
FC-SSSQfunction (/20) 11.96 ± 2.85 12.00 ± 4.22 7.39 ± 2.89 0.001* †
FC-SSSQtotal (/55) 33.26 ± 6.29 33.86 ± 6.01 21.56 ± 5.38 < 0.001* †
TSK (/68) 45.43 ± 8.39 38.46 ± 8.13 34.39 ± 7.91 < 0.001*#
EQ-VAS score (/100) 73.00 ± 18.38 66.79 ± 18.18 78.44 ± 6.78 0.118
  1. * p < 0.001 between the LSS group and the nLBP group
  2. p < 0.001 between the PAD group and the nLBP group
  3. # p < 0.05 between the LSS group and the PAD group
  4. LSS: Lumbar Spinal Stenosis, PAD: Peripheral Arterial Disease, nLBP: non-specific Low Back Pain, F: female, M: male, BMI: Body Mass Index, WIQ: Walking Impairment Questionnaire, FC-SSSQ: French-Canadian Swiss Spinal Stenosis Questionnaire, TSK: Tampa Scale of Kinesiophobia, EQ-VAS score: EQ-5D: European Questionnaire– 5 dimensions Visual Analog Scale